Cosmos Health Stock (NASDAQ:COSM)

Revenue Ownership Financials Chart

Previous Close

$1.00

52W Range

$0.47 - $2.05

50D Avg

$1.17

200D Avg

$0.93

Market Cap

$17.15M

Avg Vol (3M)

$2.46M

Beta

3.13

Div Yield

COSM Company Profile

Cosmos Health Inc. operates as a vertically integrated pharmaceutical company. It offers a proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter medications, health care and baby products, medical devices, and other products through its distribution channels and an ecommerce marketplace. The company identifies, acquires, develops, and commercializes products that enhance patients' lives and outcomes, as well as has distribution centers in Greece and the United Kingdom; and operates a warehousing facility. It serves wholesale pharmaceutical distributors and independent retail pharmacies. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.

Industry

Drug Manufacturers - Specialty & Generic

Sector

Healthcare

Exchange

NASDAQ

ADR

Country

Employees

123

IPO Date

Jul 23, 2010

Website

COSM Performance

Revenue Breakdown

Revenue Breakdown by Product/Service

Product/Service	Dec 23
Other	-

Fiscal year ends in Dec 23 | Currency in USD

COSM Financial Summary

	Dec 23	Dec 22	Dec 21
Revenue	$53.38M	$50.35M	$56.24M
Operating Income	$-21.83M	$-7.47M	$-4.53M
Net Income	$-18.54M	$-13.83M	$-7.96M
EBITDA	$-21.22M	$-9.47M	$-4.13M
Basic EPS	$-1.55	$-7.17	$-12.12
Diluted EPS	$-1.55	$-7.17	$-12.12

Fiscal year ends in Dec 23 | Currency in USD

Peer Comparison

Ticker	Company
TLRY	Tilray Brands, Inc.
SBFM	Sunshine Biopharma, Inc.
LFCR	Lifecore Biomedical, Inc.
GHSI	Guardion Health Sciences, Inc.
IRWD	Ironwood Pharmaceuticals, Inc.
ALIM	Alimera Sciences, Inc.
SHPH	Shuttle Pharmaceuticals Holdings, Inc.
PTPI	Petros Pharmaceuticals, Inc.
ADMP	Adamis Pharmaceuticals Corporation
LSDI	Lucy Scientific Discovery Inc.
CTLT	Catalent, Inc.
SXTC	China SXT Pharmaceuticals, Inc.